Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment

摘要

The invention relates to the use of idrabiotaparinux for the treatment and secondary prevention of thrombotic pathologies, wherein the use of idrabiotaparinux involves a decrease in the incidence of bleedings, in particular major bleedings, during said treatment.